CN110964020B - Method for preparing 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] compound - Google Patents

Method for preparing 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] compound Download PDF

Info

Publication number
CN110964020B
CN110964020B CN201811140270.7A CN201811140270A CN110964020B CN 110964020 B CN110964020 B CN 110964020B CN 201811140270 A CN201811140270 A CN 201811140270A CN 110964020 B CN110964020 B CN 110964020B
Authority
CN
China
Prior art keywords
indoline
compound
pyrrole
diazo
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201811140270.7A
Other languages
Chinese (zh)
Other versions
CN110964020A (en
Inventor
万伯顺
钱磊磊
易如霞
吴凡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Institute of Chemical Physics of CAS
Original Assignee
Dalian Institute of Chemical Physics of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Institute of Chemical Physics of CAS filed Critical Dalian Institute of Chemical Physics of CAS
Priority to CN201811140270.7A priority Critical patent/CN110964020B/en
Publication of CN110964020A publication Critical patent/CN110964020A/en
Application granted granted Critical
Publication of CN110964020B publication Critical patent/CN110964020B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to a method for preparing 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] derivatives. In particular to a method for preparing 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] derivatives by 3-diazoindoline compounds and ethylene azide compounds under the action of transition metals. The method provided by the invention is used for preparing the 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] derivative from simple and easily available raw materials through simple operation steps.

Description

Method for preparing 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] compound
Technical Field
The invention relates to a method for preparing a 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] compound.
Background
Spiro heterocyclic compounds are common frameworks in natural products, drug molecules and many types of catalysts, and indole spiro pyrrole compounds are a very important type of them as a general synthetic module. Various spiro [ indoline-3, 2' -pyrroles ] have interesting structural properties and highly potent pharmacological activities, including anticancer activity, cholinesterase inhibitors, advanced glycosylation end product activity, antibacterial activity and antidiabetic activity. Its biological activity should be related to the spiro assembly of its two part important modules. Based on their activities, various synthetic methods have been reported in recent years, including 1, 3-dipolar cycloaddition, nucleophilic addition, intramolecular hydroamination, homoenol addition, Buchwald-Hartwig/Michael reaction, aromatization, reductive cyclization, etc., but at present, no method for providing a pyrrole ring structure by a domino reaction with an azidoalkenyl group has been reported. A simple one-step process for preparing 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] compounds from 3-diazoindoline compounds and vinyl azides is described.
Disclosure of Invention
The invention aims to provide a method for synthesizing a 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] compound.
Figure BDA0001815646480000021
Reaction equation 1: the specific operation steps for synthesizing the 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] compound are as follows (reaction equation 1):
reacting in a reactor, adding 3-diazoindoline 1 and vinyl azide 2, then adding a solvent and a catalyst, and reacting at 0-100 ℃, preferably 60 ℃ for 12-36 hours, preferably 24 hours; after the reaction is finished, separating to obtain the 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] compound 3.
The molar ratio of the vinyl azide 2 to the 3-diazoindoline 1 is 1-10:1, and the preferred ratio is 7: 1.
The catalyst being Rh2(OAc)4、Rh2(Oct)4、Rh2(TFA)4、Rh2(OAc)4One or more of rhodium octanoate, rhodium (II) hexanoate dimer, rhodium (II) tetrakis (triphenylacetate) dichlormethane adduct, and rhodium (II) trimethylacetate dimer, preferably Rh2(TFA)4(ii) a The amount of the catalyst is 0 to 100mol percent, preferably 5mol percent of the amount of the 3-diazoindoline 1.
The solvent is one or more of 1, 2-dichloroethane, dichloromethane, chloroform, 1,2, 2-tetrachloroethane, chlorobenzene, trifluorotoluene, 1, 4-dioxane and toluene, preferably 1, 2-dichloroethane; the amount of solvent used is 5 to 50 ml, preferably 10 ml, per mmol of 3-diazoindoline 1.
The invention has the following advantages:
1. the synthesis process of the reactants is simple and only needs one to two steps.
2. The reaction is simple and convenient to operate, and compared with the traditional method, the reaction product can be obtained in one step.
3. The reaction yield is high.
Detailed Description
For a better understanding of the present invention, the following examples are set forth.
Figure BDA0001815646480000031
Reacting in a reactor, adding 3-diazoindoline 1(0.3mmol) and ethylene azide 2(7eq.), and then adding Rh2(TFA)4(5 mol%) and 1, 2-dichloroethane (3mL) at 60 ℃ for 24 hours. After the reaction is finished, the solvent is pumped out, the crude sample is dissolved in dichloromethane and loaded for silica gel column chromatography, and the 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole can be obtained]Compound 3.
The reaction materials and results of examples 1-3 are shown in Table 1.
TABLE 1
Figure BDA0001815646480000032
The characterization data for the products of examples 1-3 are as follows:
1-benzyl-5′-phenyl-3′,4′-dihydrospiro[indoline-3,2′-pyrrol]-2-one:
1H NMR(400 MHz,CDCl3)δ7.94–7.91(m,2H),7.47–7.40(m,3H),7.35–7.29(m,4H),7.27–7.23(m,1H),7.19–7.13(m,2H),7.02–6.98(dd,J=11.0,4.0 Hz,1H),6.74(d,J=7.8 Hz,1H),5.02(d,J=15.7 Hz,1H),4.83(d,J=15.7 Hz,1H),3.50(ddd,J=16.8,9.5,7.2 Hz,1H),3.38(ddd,J=17.0,9.7,4.9 Hz,1H),2.67(ddd,J=13.4,9.5,4.9 Hz,1H),2.31(ddd,J=13.1,9.7,7.2 Hz,1H).;13C NMR(101 MHz,CDCl3)δ177.57,177.43,142.87,135.80,133.86,132.31,131.22,129.16,128.87,128.50,128.40,127.67,127.41,123.75,123.17,109.42,81.62,44.04,36.84,33.22.
5′-phenyl-1-tosyl-3′,4′-dihydrospiro[indoline-3,2′-pyrrol]-2-one:
1H NMR(400 MHz,CDCl3)δ8.00(d,J=8.4 Hz,2H),7.95(d,J=8.2 Hz,1H),7.84–7.82(m,2H),7.48–7.45(m,1H),7.41–7.36(m,3H),7.31(d,J=8.1 Hz,2H),7.20–7.12(m,2H),3.44–3.29(m,2H),2.61(ddd,J=13.4,8.8,4.7 Hz,1H),2.41(s,3H),2.21(ddd,J=13.4,9.4,8.3 Hz,1H).;13C NMR(101 MHz,CDCl3)δ178.75,175.43,145.81,139.04,135.26,133.41,131.61,131.24,129.97,129.93,128.61,128.45,128.12,125.49,124.16,113.85,81.64,36.59,34.73,21.83.
1-benzoyl-5′-phenyl-3′,4′-dihydrospiro[indoline-3,2′-pyrrol]-2-one:
1H NMR(400 MHz,CDCl3)δ7.95–7.89(m,3H),7.77–7.75(m,2H),7.57–7.53(m,1H),7.49–7.39(m,6H),7.24(d,J=3.7 Hz,2H),3.47–3.33(m,2H),2.67(ddd,J=13.7,8.4,5.4 Hz,1H),2.38–2.30(m,1H).;13C NMR(101 MHz,CDCl3)δ178.00,176.99,169.46,140.18,134.24,133.58,132.89,131.79,131.54,129.69,129.48,128.64,128.46,128.30,125.66,123.92,115.50,82.13,36.98,33.87.
comparative example 1:
the operation process is the same as that of example 1, except that the catalyst is PPh3AuCl/AgSbF6(1/1, 3 mol%) and yield of product 3 was 0%.
Comparative example 2:
the procedure was as in example 1, except that in example 1, the yield of product 3 was 0% without using any catalyst.

Claims (5)

1. A process for preparing a 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] derivative, characterized in that:
3-diazo dihydro indoline compound 1 and vinyl azide compound 2 shown in the following formula are taken as raw materials to generate 3 ', 4 ' -dihydro spiro [ indoline-3, 2 ' -pyrrole ] derivative 3, and the reaction formula is as follows:
Figure DEST_PATH_IMAGE001
R2selected from fluorine, chlorine, bromine, trifluoromethyl, C1-C5 alkyl, R1Selected from arylsulfonyl, R3Selected from unsubstituted phenyl; the specific operation steps are as follows:
reacting in a reactor, adding 3-diazo dihydro indoline compound 1 and vinyl azide compound 2, then adding solvent and catalyst, and reacting at 60-100 ℃; reacting for 12-36 hours; after the reaction is finished, separating to obtain a 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] derivative 3;
the catalyst being Rh2(TFA)4(ii) a The dosage of the catalyst is 0 to 5mol percent of that of the 3-diazo dihydro indoline compound 1 and is not 0.
2. The method of claim 1, wherein:
the molar ratio of the vinyl azide compound 2 to the 3-diazo dihydro indoline compound 1 is 1-50: 1.
3. A method as claimed in claim 2, characterized in that: the molar ratio of the vinyl azide compound 2 to the 3-diazo dihydro indoline compound 1 is 7: 1.
4. The method of claim 1, wherein:
the solvent is one or more than two of 1, 2-dichloroethane, dichloromethane, chloroform, 1,2, 2-tetrachloroethane, chlorobenzene, trifluorotoluene, 1, 4-dioxane and toluene; the amount of the solvent is 5-50 ml per millimole of the 3-diazo dihydro indoline compound 1.
5. The method of claim 4, wherein:
the solvent is 1, 2-dichloroethane; the amount of the solvent used was 10 ml per mmol of the 3-diazo dihydroindoline compound 1.
CN201811140270.7A 2018-09-28 2018-09-28 Method for preparing 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] compound Active CN110964020B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811140270.7A CN110964020B (en) 2018-09-28 2018-09-28 Method for preparing 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811140270.7A CN110964020B (en) 2018-09-28 2018-09-28 Method for preparing 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] compound

Publications (2)

Publication Number Publication Date
CN110964020A CN110964020A (en) 2020-04-07
CN110964020B true CN110964020B (en) 2022-06-14

Family

ID=70027819

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811140270.7A Active CN110964020B (en) 2018-09-28 2018-09-28 Method for preparing 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] compound

Country Status (1)

Country Link
CN (1) CN110964020B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080125430A1 (en) * 2006-08-30 2008-05-29 The Regents Of The University Of Michigan New small molecule inhibitors of mdm2 and the uses thereof
WO2009143156A2 (en) * 2008-05-19 2009-11-26 Sepracor Inc. IMIDAZO[1,2-a]PYRIDINE COMPOUNDS
CN102268000A (en) * 2011-05-05 2011-12-07 温州医学院 Novel spiroheterocyclic compound and application of same serving as therapeutic agent
CN102659786A (en) * 2012-04-16 2012-09-12 上海大学 6a,7-dihydro-m-diaza naphthalene [1,2-a]-quinazoline-5,8(6H)-diketone and preparation method thereof
CN103483344A (en) * 2013-09-11 2014-01-01 常州大学 Method for synthesizing oxindole spiro compound

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080125430A1 (en) * 2006-08-30 2008-05-29 The Regents Of The University Of Michigan New small molecule inhibitors of mdm2 and the uses thereof
WO2009143156A2 (en) * 2008-05-19 2009-11-26 Sepracor Inc. IMIDAZO[1,2-a]PYRIDINE COMPOUNDS
CN102268000A (en) * 2011-05-05 2011-12-07 温州医学院 Novel spiroheterocyclic compound and application of same serving as therapeutic agent
CN102659786A (en) * 2012-04-16 2012-09-12 上海大学 6a,7-dihydro-m-diaza naphthalene [1,2-a]-quinazoline-5,8(6H)-diketone and preparation method thereof
CN103483344A (en) * 2013-09-11 2014-01-01 常州大学 Method for synthesizing oxindole spiro compound

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"[1+1+3] Annulation of Diazoenals and Vinyl Azides: Direct Synthesis of Functionalized 1-Pyrrolines through Olefination"及其Supporting Information;Vinaykumar Kanchupalli等,;《Angew. Chem. Int. Ed.》;20180406(第57期);第5433–5437页及其Supporting Information第S1-S52页 *
"Construction of 1-pyrroline skeletons by Lewis acid-mediated conjugate addition of vinyl azides"及其Electronic Supplementary Information;Xu Zhu等,;《Chem. Commun.》;20160104(第52期);第2473-2476页及其Electronic Supplementary Information第S1-S37页 *

Also Published As

Publication number Publication date
CN110964020A (en) 2020-04-07

Similar Documents

Publication Publication Date Title
CN102627650A (en) Chiral spiro(pyrrolidine-3, 2'-oxindole)compound and synthesis method thereof
CN102432608A (en) Method for synthesizing optically active tetrahydro-beta-carboline derivative through catalysis of chiral spirocyclic phosphoric acid
CN110964020B (en) Method for preparing 3 ', 4 ' -dihydrospiro [ indoline-3, 2 ' -pyrrole ] compound
JP2020512323A (en) Process for producing kinase inhibitor having sulfonamide structure
Massacret et al. Palladium (0)‐Catalyzed Asymmetric Synthesis of 1, 2, 3, 4‐Tetrahydro‐2‐vinylquinoxalines
CN113582993B (en) Condensed polycyclic compound containing triazahydronaphthalene structure and preparation method and application thereof
Mukherjee et al. Facile synthesis of functionalized 6-cyano-2-oxa-7-azabicyclo [4.1. 0] hept-3-en-1-yl acetates: a catalyst free approach to access the pyran fused 2-acetoxy-NH-aziridines
CN108658999B (en) Synthesis method of 2-phenyl heterocyclic [2,3-d ] pyrimidine-4 (3H) -ketone compound
CN108129402B (en) Method for synthesizing 2-phenyl quinazolinone compound by taking tolane compound as raw material
CN112979529B (en) Aromatic amine indole naphthoquinone derivative and preparation method thereof
CN111732516A (en) A kind ofNProcess for preparing (E) -aryl-substituted heterocyclic compounds
CN104860881A (en) Methods for synthesizing 8-(nitro methyl) quinoline compounds and 8-methylamino tetrahydroquinoline compounds
KR101808274B1 (en) 1,3-Disubstituted isoindoline compounds and Method for the stereoselective preparation thereof
CN113200902B (en) Polysubstituted pyrrole derivative and preparation method thereof
KR20170016756A (en) New method for preparation of chiral chromanol derivatives
KR101521092B1 (en) Process for the preparation of arylamide and enamide derivatives using organic axide and iridium catalyst
KR101885084B1 (en) Novel amidation of N-acyl indole derivatives
Harrak et al. Two alternatives for the synthesis of pyrrolo [1, 2-a] quinoxaline derivatives
KR101578504B1 (en) - Novel preparation method of quinoline -oxide derivative with amide group
KR102292794B1 (en) Preparation method of 2-substituted 1,2,3,4-tetrahydroquinoline compound
CN115260096B (en) Method for synthesizing dihydroisoquinolinones based on carbon monoxide gas or carbon monoxide substitution source
CN111732528B (en) Preparation method of N-aryl indoline derivative
KR102088972B1 (en) Benzosulfamidate-fused-isoindoline compounds and method for the stereoselective preparation thereof
CN109467558B (en) 1-hydropyrrolizine derivative and synthesis method and application thereof
CN111233735B (en) Method for preparing di (2-indolyl) acetylene derivative

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant